38 related articles for article (PubMed ID: 38688610)
21. Predictive factors associated with complete pathological response after neoadjuvant treatment for rectal cancer.
Hajer J; Rim A; Ghorbel A; Amani Y; Ines L; Asma B; Chiraz N
Cancer Radiother; 2021 May; 25(3):259-267. PubMed ID: 33422417
[TBL] [Abstract][Full Text] [Related]
22. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes.
Baidoun F; Elshiwy K; Elkeraie Y; Merjaneh Z; Khoudari G; Sarmini MT; Gad M; Al-Husseini M; Saad A
Curr Drug Targets; 2021; 22(9):998-1009. PubMed ID: 33208072
[TBL] [Abstract][Full Text] [Related]
23. Ten-year survival after pathologic complete response in rectal adenocarcinoma.
Sell NM; Qwaider YZ; Goldstone RN; Cauley CE; Cusack JC; Ricciardi R; Bordeianou LG; Berger DL; Kunitake H
J Surg Oncol; 2021 Jan; 123(1):293-298. PubMed ID: 33022797
[TBL] [Abstract][Full Text] [Related]
24. Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes.
DI Tommaso M; Rosa C; Caravatta L; Augurio A; Borzillo V; DI Santo S; Perrotti F; Taraborrelli M; Cianci R; Innocenti P; DI Sebastiano P; Colasante A; Angelucci D; Basti M; Sindici G; Mazzola L; Pizzicannella G; DI Bartolomeo N; Marchioni M; DI Nicola M; Genovesi D
In Vivo; 2020; 34(3):1223-1233. PubMed ID: 32354913
[TBL] [Abstract][Full Text] [Related]
25. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Sakin A; Sahin S; Sengul Samanci N; Yasar N; Demir C; Geredeli C; Erhan SS; Akboru MH; Cihan S
J Oncol Pharm Pract; 2020 Oct; 26(7):1611-1620. PubMed ID: 32046577
[TBL] [Abstract][Full Text] [Related]
26. Complete Pathological Response Following Radiochemotherapy for Locally Advanced Rectal Cancer: Short and Long-term Outcome.
Iskander O; Courtot L; Tabchouri N; Artus A; Michot N; Muller O; Pabst-Giger U; Bourlier P; Kraemer-Bucur A; Lecomte T; Guyetant S; Chapet S; Calais G; Salamé E; Ouaïssi M
Anticancer Res; 2019 Sep; 39(9):5105-5113. PubMed ID: 31519622
[TBL] [Abstract][Full Text] [Related]
27. Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome.
Jalilian M; Davis S; Mohebbi M; Sugamaran B; Porter IW; Bell S; Warrier SK; Wale R
J Gastrointest Oncol; 2016 Aug; 7(4):603-8. PubMed ID: 27563451
[TBL] [Abstract][Full Text] [Related]
28. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
29. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Sauer R; Liersch T; Merkel S; Fietkau R; Hohenberger W; Hess C; Becker H; Raab HR; Villanueva MT; Witzigmann H; Wittekind C; Beissbarth T; Rödel C
J Clin Oncol; 2012 Jun; 30(16):1926-33. PubMed ID: 22529255
[TBL] [Abstract][Full Text] [Related]
30. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.
Martin ST; Heneghan HM; Winter DC
Br J Surg; 2012 Jul; 99(7):918-28. PubMed ID: 22362002
[TBL] [Abstract][Full Text] [Related]
31. Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer.
Dhadda AS; Dickinson P; Zaitoun AM; Gandhi N; Bessell EM
Eur J Cancer; 2011 May; 47(8):1138-45. PubMed ID: 21220198
[TBL] [Abstract][Full Text] [Related]
32. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival.
Rosenberg R; Nekarda H; Zimmermann F; Becker K; Lordick F; Hofler H; Molls M; Siewert JR
J Surg Oncol; 2008 Jan; 97(1):8-13. PubMed ID: 18085619
[TBL] [Abstract][Full Text] [Related]
33. Integration of novel agents into combined-modality treatment for rectal cancer patients.
Rödel C; Sauer R
Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
[TBL] [Abstract][Full Text] [Related]
34. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
[TBL] [Abstract][Full Text] [Related]
35. Preoperative versus postoperative chemoradiotherapy for rectal cancer.
Sauer R; Becker H; Hohenberger W; Rödel C; Wittekind C; Fietkau R; Martus P; Tschmelitsch J; Hager E; Hess CF; Karstens JH; Liersch T; Schmidberger H; Raab R;
N Engl J Med; 2004 Oct; 351(17):1731-40. PubMed ID: 15496622
[TBL] [Abstract][Full Text] [Related]
36. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.
Mandard AM; Dalibard F; Mandard JC; Marnay J; Henry-Amar M; Petiot JF; Roussel A; Jacob JH; Segol P; Samama G
Cancer; 1994 Jun; 73(11):2680-6. PubMed ID: 8194005
[TBL] [Abstract][Full Text] [Related]
37. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).
Cox JD; Stetz J; Pajak TF
Int J Radiat Oncol Biol Phys; 1995 Mar; 31(5):1341-6. PubMed ID: 7713792
[No Abstract] [Full Text] [Related]
38. Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal Cancer: A Mono Institutional Experience.
Lucarelli M; Gentile V; Bonelli R; Pasquale G; Pizzi AD; Nicola MD; Porreca A; Genovesi D
In Vivo; 2024; 38(3):1367-1374. PubMed ID: 38688610
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
